Journal article
Using cancer genomics to guide clinical decisions
Cancer, Vol.123(8), pp.1288-1291
04/15/2017
DOI: 10.1002/cncr.30640
PMCID: PMC5789460
PMID: 28253425
Abstract
Genomic tests now provide unprecedented insight into what drives cancer; however, using this information in the clinic remains a challenge. This article provide insights into interpreting and using genomic tests for clinical decisions based on experience in leading molecular tumor boards.
Details
- Title: Subtitle
- Using cancer genomics to guide clinical decisions
- Creators
- Mark E. Burkard - Univ Wisconsin, Dept Med, Hematol Oncol, Madison, WI 53706 USADustin A. Deming - Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USAJosh Lauring - Johns Hopkins University
- Resource Type
- Journal article
- Publication Details
- Cancer, Vol.123(8), pp.1288-1291
- Publisher
- Wiley
- DOI
- 10.1002/cncr.30640
- PMID
- 28253425
- PMCID
- PMC5789460
- ISSN
- 0008-543X
- eISSN
- 1097-0142
- Number of pages
- 4
- Grant note
- P30 CA014520 / UW Carbone Cancer Center Core Grant IRSA 1014160 / Burroughs Welcome Fund; Burroughs Wellcome Fund P30CA014520 / NATIONAL CANCER INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) BC150425P1 / DOD Breast Cancer Research Program; United States Department of Defense
- Language
- English
- Date published
- 04/15/2017
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984700649902771
Metrics
4 Record Views